The shift toward long-acting reversible contraceptives (LARCs) reflects a growing preference among patients and healthcare providers for highly effective, low-maintenance reproductive health solutions. Subdermal implants, which release a continuous low dose of progestin over several years, offer a primary advantage by removing user adherence errors from daily or monthly routines. This...